Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
clinical trials
fda
life sciences
national blog main
3
×
amgen
eli lilly
migraine
national
national top stories
abbvie
allergan
billy dunn
biogen
biohaven
calcitonin gene-related peptide
cgpr
chronic migraine
drug prices
drug pricing
drugs
episodic migraine
europe blog main
europe top stories
evrysdi
gene therapy
genentech
indiana
indiana blog main
indiana top stories
ionis pharmaceuticals
merck
new york blog main
new york top stories
novartis
nusinersen
risdiplam
rna drugs
roche
san francisco top stories
What
approved
3
×
fda
new
3
×
class
drug
medicines
migraine
adults
allergan
announced
approval
atrophy
daily
decision
developed
eli
evrysdi
friday
green
headache
home
intended
late
lights
lilly
liquid
marks
medicine
monday
muscular
nod
oral
pain
patients
pill
prevent
risdiplam
roche
spinal
starts
Language
unset
Current search:
approved
×
biotech
×
" national blog main "
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines